Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and bisindolylmaleimide i

erlotinib hydrochloride has been researched along with bisindolylmaleimide i in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(bisindolylmaleimide i)		Trials
(bisindolylmaleimide i)		Recent Studies (post-2010) (bisindolylmaleimide i)
4,3537863,0331,1981174

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)bisindolylmaleimide i (IC50)
Chain A, Protein kinase C, iotaHomo sapiens (human)5.8
3-phosphoinositide-dependent protein kinase 1Homo sapiens (human)9
G2/mitotic-specific cyclin-B2Homo sapiens (human)2.3
cAMP-dependent protein kinase catalytic subunit alphaBos taurus (cattle)0.5
Protein kinase C gamma typeHomo sapiens (human)0.03
Protein kinase C beta typeHomo sapiens (human)0.0054
Cyclin-dependent kinase 1Homo sapiens (human)2.3
Serine/threonine-protein kinase pim-1Homo sapiens (human)0.068
Cyclin-dependent kinase 4Homo sapiens (human)0.99
G2/mitotic-specific cyclin-B1Homo sapiens (human)2.3
Lethal factorBacillus anthracis1.5
Protein kinase C alpha typeHomo sapiens (human)0.0055
Glycogen synthase kinase-3 betaRattus norvegicus (Norway rat)0.36
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoformOryctolagus cuniculus (rabbit)0.7
G1/S-specific cyclin-D1Homo sapiens (human)0.99
Protein kinase C eta typeHomo sapiens (human)0.0066
G1/S-specific cyclin-E1Homo sapiens (human)0.99
Cyclin-dependent kinase 2Homo sapiens (human)0.99
cAMP-dependent protein kinase catalytic subunit alpha Rattus norvegicus (Norway rat)2
Protein kinase C iota typeHomo sapiens (human)3.463
Glycogen synthase kinase-3 betaHomo sapiens (human)0.19
Protein kinase C epsilon typeHomo sapiens (human)0.0067
Protein kinase C theta typeHomo sapiens (human)0.0061
Protein kinase C zeta typeHomo sapiens (human)5.8
Protein kinase C delta typeHomo sapiens (human)0.0096
Peroxisome proliferator-activated receptor alphaHomo sapiens (human)0.006
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)1
NAD-dependent protein deacetylase sirtuin-2Homo sapiens (human)7.3
G2/mitotic-specific cyclin-B3Homo sapiens (human)2.3
Serine/threonine-protein kinase LMTK3Homo sapiens (human)0.0001

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballestrero, A; Bauer, I; Castiglioni, I; D'Agostino, V; Feldmann, G; Latorre, E; Nencioni, A; Pancher, M; Provenzani, A; Thongon, N; Zucal, C1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and bisindolylmaleimide i

ArticleYear
The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level.
    Oncotarget, 2016, May-03, Volume: 7, Issue:18

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Maleimides; Pancreatic Neoplasms; Phosphoproteins; Smad Proteins; Transcription Factors; YAP-Signaling Proteins

2016